Claims for Patent: 8,466,194

Summary for Patent: 8,466,194

Title:	Spiroketals
Abstract:	The present invention relates to spiroketal compounds that are useful in methods of treating or preventing protozoal infections, parasitic infections, bacterial infections, cell proliferative disorders and anti inflammatory disorders. The spiroketal compounds are also useful as immunosuppressive agents, and also in methods of controlling pests.
Inventor(s):	Reddell; Paul Warren (Yungaburra, AU), Gordon; Victoria Anne (Yungaburra, AU)
Assignee:	EcoBiotics, Ltd (Yungaburra, Queensland, AU)
Application Number:	13/208,210
Patent Claims:	1. A method of treating cancer, wherein the cancer is selected from the group consisting of leukemia, melanoma, prostate cancer, breast cancer, ovarian cancer, basal cell carcinoma, squamous cell carcinoma, fibrosarcoma, colon cancer, lung cancer, and a neoplasm, comprising administering to a subject a compound of formula (II): ##STR00035## wherein X, Y and Z are independently selected from --O--, --S--, --NH--, --N(C.sub.1-C.sub.6 alkyl)- and --CH.sub.2--; R.sup.50 is selected from --CH.sub.3, --C.sub.3-C.sub.8 cycloalkyl, aryl, heterocyclyl and heteroaryl; R.sup.51, R.sup.52, R.sup.57, R.sup.58, R.sup.61, R.sup.62, R.sup.67, R.sup.68, R.sup.69 and R.sup.70 are independently selected from hydrogen, --C.sub.1-C.sub.20 alkyl, --C.sub.2-C.sub.20 alkenyl, --C.sub.2-C.sub.20 alkynyl, --C.sub.3-C.sub.8 cycloalkyl, --C.sub.6-C.sub.14 aryl, --C.sub.5-C.sub.14 heteroaryl, --C.sub.3-C.sub.14 heterocyclyl, arylalkyl, heteroarylalkyl, heterocyclylalkyl, alkoxyalkyl, halo, --CN, --NO.sub.2, --C.sub.1-C.sub.10 haloalkyl, --C.sub.1-C.sub.10 dihaloalkyl, --C.sub.1-C.sub.10 trihaloalkyl, --COR, --CO.sub.2R, --OR, --SR, --N(R).sub.2, --NROR, --ON(R).sub.2, --SOR, --SO.sub.2R, --SO.sub.3R, --SON(R).sub.2, --SO.sub.2N(R).sub.2, --SO.sub.3N(R).sub.2, --P(R).sub.3, --P(O)(R).sub.3, --OSi(R).sub.3, --OB(R).sub.2, --C(W)R and --WC(W)R; R.sup.53 to R.sup.56 are independently selected from hydrogen, --C.sub.1-C.sub.20 alkyl, --C.sub.2-C.sub.20 alkenyl, --C.sub.2-C.sub.20 alkynyl, --C.sub.3-C.sub.8 cycloalkyl, --C.sub.6-C.sub.14 aryl, --C.sub.5-C.sub.14 heteroaryl, --C.sub.3-C.sub.14 heterocyclyl, arylalkyl, heteroarylalkyl, heterocyclylalkyl, alkoxyalkyl, halo, --CN, --NO.sub.2, --C.sub.1-C.sub.10 haloalkyl, --C.sub.1-C.sub.10 dihaloalkyl, --C.sub.1-C.sub.10 trihaloalkyl, --COR, --CO.sub.2R, --OR, --SR, --N(R).sub.2, --NROR, --ON(R).sub.2, --SOR, --SO.sub.2R, --SO.sub.3R, --SON(R).sub.2, --SO.sub.2N(R).sub.2, --SO.sub.3N(R).sub.2, --P(R).sub.3, --P(O)(R).sub.3, --OSi(R).sub.3, --OB(R).sub.2, --C(W)R and --WC(W)R; or R.sup.54 and R.sup.55 taken together form a double bond or are --O--; or R.sup.53 and R.sup.54 or R.sup.55 and R.sup.56 taken together form a carbonyl group; R.sup.59 and R.sup.60 are independently selected from hydrogen, --C.sub.1-C.sub.20 alkyl, --C.sub.2-C.sub.20 alkenyl, --C.sub.2-C.sub.20 alkynyl, --C.sub.3-C.sub.8 cycloalkyl, --C.sub.6-C.sub.14 aryl, --C.sub.5-C.sub.14 heteroaryl, --C.sub.3-C.sub.14 heterocyclyl, arylalkyl, heteroarylalkyl, heterocyclylalkyl, alkoxyalkyl, halo, --CN, --NO.sub.2, --C.sub.1-C.sub.10 haloalkyl, --C.sub.1-C.sub.10 dihaloalkyl, --C.sub.1-C.sub.10 trihaloalkyl, --COR, --CO.sub.2R, --OR, --SR, --N(R).sub.2, --NROR, --ON(R).sub.2, --SOR, --SO.sub.2R, --SO.sub.3R, --SON(R).sub.2, --SO.sub.2N(R).sub.2, --SO.sub.3N(R).sub.2, --P(R).sub.3, --P(O)(R).sub.3, --OSi(R).sub.3, --OB(R).sub.2, --C(W)R and --WC(W)R; or R.sup.59 and R.sup.60 taken together form a carbonyl group; R.sup.63 to R.sup.66 are independently selected from hydrogen, --C.sub.1-C.sub.20 alkyl, --C.sub.2-C.sub.20 alkenyl, --C.sub.2-C.sub.20 alkynyl, --C.sub.3-C.sub.8 cycloalkyl, --C.sub.6-C.sub.14 aryl, --C.sub.5-C.sub.14 heteroaryl, --C.sub.3-C.sub.14 heterocyclyl, arylalkyl, heteroarylalkyl, heterocyclylalkyl, alkoxyalkyl, halo, --CN, --NO.sub.2, --C.sub.1-C.sub.10 haloalkyl, --C.sub.1-C.sub.10 dihaloalkyl, --C.sub.1-C.sub.10 trihaloalkyl, --COR, --CO.sub.2R, --OR, --SR, --N(R).sub.2, --NROR, --ON(R).sub.2, --SOR, --SO.sub.2R, --SO.sub.3R, --SON(R).sub.2, --SO.sub.2N(R).sub.2, --SO.sub.3N(R).sub.2, --P(R).sub.3, --P(O)(R).sub.3, --OSi(R).sub.3, --OB(R).sub.2, --C(W)R and --WC(W)R; or R.sup.64 and R.sup.65 taken together form a double bond or are --O--; or R.sup.63 and R.sup.64 or R.sup.65 and R.sup.66 taken together form a carbonyl group; R.sup.71 and R.sup.72 are independently selected from hydrogen, --C.sub.1-C.sub.20 alkyl, --C.sub.2-C.sub.20 alkenyl, --C.sub.2-C.sub.20 alkynyl, --C.sub.3-C.sub.8 cycloalkyl, --C.sub.6-C.sub.14 aryl, --C.sub.5-C.sub.14 heteroaryl, --C.sub.3-C.sub.14 heterocyclyl, arylalkyl, heteroarylalkyl, heterocyclylalkyl, alkoxyalkyl, halo, --CN, --NO.sub.2, --C.sub.1-C.sub.10 haloalkyl, --C.sub.1-C.sub.10 dihaloalkyl, --C.sub.1-C.sub.10 trihaloalkyl, --COR, --CO.sub.2R, --OR, --SR, --N(R).sub.2, --NROR, --ON(R).sub.2, --SOR, --SO.sub.2R, --SO.sub.3R, --SON(R).sub.2, --SO.sub.2N(R).sub.2, --SO.sub.3N(R).sub.2, --P(R).sub.3, --P(O)(R).sub.3, --OSi(R).sub.3, --OB(R).sub.2, --C(W)R and --WC(W)R; or R.sup.71 and R.sup.72 taken together form a carbonyl group; R.sup.73 to R.sup.76 are independently selected from hydrogen, --C.sub.1-C.sub.20 alkyl, --C.sub.2-C.sub.20 alkenyl, --C.sub.2-C.sub.20 alkynyl, --C.sub.3-C.sub.8 cycloalkyl, --C.sub.6-C.sub.14 aryl, --C.sub.5-C.sub.14 heteroaryl, --C.sub.3-C.sub.14 heterocyclyl, arylalkyl, heteroarylalkyl, heterocyclylalkyl, alkoxyalkyl, halo, --CN, --NO.sub.2, --C.sub.1-C.sub.10 haloalkyl, --C.sub.1-C.sub.10 dihaloalkyl, --C.sub.1-C.sub.10 trihaloalkyl, --COR, --CO.sub.2R, --OR, --SR, --N(R).sub.2, --NROR, --ON(R).sub.2, --SOR, --SO.sub.2R, --SO.sub.3R, --SON(R).sub.2, --SO.sub.2N(R).sub.2, --SO.sub.3N(R).sub.2, --P(R).sub.3, --P(O)(R).sub.3, --OSi(R).sub.3, --OB(R).sub.2, --C(W)R and --WC(W)R; or R.sup.74 and R.sup.75 taken together form a double bond or are --O--; or R.sup.73 and R.sup.74 or R.sup.75 and R.sup.76 taken together form a carbonyl group; R.sup.77 and R.sup.78 are independently selected from hydrogen, --C.sub.1-C.sub.10 alkyl, --C.sub.2-C.sub.10 alkenyl and --C.sub.2-C.sub.10 alkynyl; W is selected from --O--, --S--, --NH-- and --N(C.sub.1-C.sub.6 alkyl)-; R is selected from hydrogen, --C.sub.1-C.sub.20 alkyl, --C.sub.2-C.sub.20 alkenyl, --C.sub.2-C.sub.20 alkenyl, --C.sub.3-C.sub.8 cycloalkyl, --C.sub.6-C.sub.14 aryl, --C.sub.5-C.sub.14 heteroaryl, --C.sub.3-C.sub.14 heterocyclyl, arylalkyl, heteroarylalkyl, heterocyclylalkyl, --C.sub.1-C.sub.10 haloalkyl, --C.sub.1-C.sub.10 dihaloalkyl and --C.sub.1-C.sub.10 trihaloalkyl; p and q are independently 0 or 1; and r is an integer from 1 to 8; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocyclyl and heteroaryl is optionally substituted; or a pharmaceutically, agriculturally or pesticidally acceptable salt thereof. 2. The method according to claim 1, wherein in the compound of Formula (II), X, Y and Z are independently selected from --O-- and --S--; R.sup.50 is selected from --CH.sub.3, --C.sub.3-C.sub.8 cycloalkyl, aryl, heterocyclyl and heteroaryl; R.sup.51, R.sup.52, R.sup.57, R.sup.58, R.sup.61, R.sup.62, R.sup.67, R.sup.68, R.sup.69 and R.sup.70 are independently selected from hydrogen, --C.sub.1-C.sub.20 alkyl, --C.sub.2-C.sub.20 alkenyl, --C.sub.2-C.sub.20 alkynyl, --C.sub.3-C.sub.8 cycloalkyl, --C.sub.6-C.sub.14 aryl, --C.sub.5-C.sub.14 heteroaryl, --C.sub.3-C.sub.14 heterocyclyl, arylalkyl, heteroarylalkyl, heterocyclylalkyl, alkoxyalkyl, halo, --CN, --NO.sub.2, --C.sub.1-C.sub.10 haloalkyl, --C.sub.1-C.sub.10 dihaloalkyl, --C.sub.1-C.sub.10 trihaloalkyl, --COR, --CO.sub.2R, --OR, --SR, --N(R).sub.2, --NROR, --ON(R).sub.2, --SOR, --SO.sub.2R, --SO.sub.3R, --SON(R).sub.2, --SO.sub.2N(R).sub.2, --SO.sub.3N(R).sub.2, --P(R).sub.3, --P(O)(R).sub.3, --OSi(R).sub.3, --OB(R).sub.2, --C(W)R and --WC(W)R; R.sup.53 to R.sup.56 are independently selected from hydrogen, --C.sub.1-C.sub.20 alkyl, --C.sub.2-C.sub.20 alkenyl, --C.sub.2-C.sub.20 alkynyl, --C.sub.3-C.sub.8 cycloalkyl, --C.sub.6-C.sub.14 aryl, --C.sub.5-C.sub.14 heteroaryl, --C.sub.3-C.sub.14 heterocyclyl, arylalkyl, heteroarylalkyl, heterocyclylalkyl, alkoxyalkyl, halo, --CN, --NO.sub.2, --C.sub.1-C.sub.10 haloalkyl, --C.sub.1-C.sub.10 dihaloalkyl, --C.sub.1-C.sub.10 trihaloalkyl, --COR, --CO.sub.2R, --OR, --SR, --N(R).sub.2, --NROR, --ON(R).sub.2, --SOR, --SO.sub.2R, --SO.sub.3R, --SON(R).sub.2, --SO.sub.2N(R).sub.2, --SO.sub.3N(R).sub.2, --P(R).sub.3, --P(O)(R).sub.3, --OSi(R).sub.3, --OB(R).sub.2, --C(W)R and --WC(W)R; or R.sup.54 and R.sup.55 taken together form a double bond or --O--; R.sup.59 is hydrogen and R.sup.60 is selected from --OH, --OC.sub.1-C.sub.10 alkyl, --OC.sub.2-C.sub.2-10 alkenyl, --Ocycloalkyl, --Oaryl, --Oheterocyclyl, --Oheteroaryl, --OC.sub.1-C.sub.10 alkylcycloalkyl, --OC.sub.1-C.sub.10 alkylaryl, --OC.sub.1-C.sub.10 alkylheterocyclyl, --OC.sub.1-C.sub.10 alkylheteroaryl and --OC(O)R; or R.sup.59 and R.sup.60 taken together form a carbonyl group; R.sup.63 and R.sup.64 are independently selected from hydrogen, --C.sub.1-C.sub.20 alkyl, --C.sub.2-C.sub.20 alkenyl, --C.sub.2-C.sub.20 alkynyl, --C.sub.3-C.sub.8 cycloalkyl, --C.sub.6-C.sub.14 aryl, --C.sub.5-C.sub.14 heteroaryl, --C.sub.3-C.sub.14 heterocyclyl, arylalkyl, heteroarylalkyl, heterocyclylalkyl, alkoxyalkyl, halo, --CN, --NO.sub.2, --C.sub.1-C.sub.10 haloalkyl, --C.sub.1-C.sub.10 dihaloalkyl, --C.sub.1-C.sub.10 trihaloalkyl, --COR, --CO.sub.2R, --OR, --SR, --N(R).sub.2, --NROR, --ON(R).sub.2, --SOR, --SO.sub.2R, --SO.sub.3R, --SON(R).sub.2, --SO.sub.2N(R).sub.2, --SO.sub.3N(R).sub.2, --P(R).sub.3, --P(O)(R).sub.3, --OSi(R).sub.3, --OB(R).sub.2, --C(W)R and --WC(W)R; R.sup.65 is hydrogen and R.sup.66 is selected from --OH, --OC.sub.1-C.sub.10 alkyl, --OC.sub.2-C.sub.2-10 alkenyl, --Ocycloalkyl, --Oaryl, --Oheterocyclyl, --Oheteroaryl, --OC.sub.1-C.sub.10 alkylcycloalkyl, --OC.sub.1-C.sub.10 alkylaryl, --OC.sub.1-C.sub.10 alkylheterocyclyl, --OC.sub.1-C.sub.10 alkylheteroaryl and --OC(O)R; or R.sup.65 and R.sup.66 taken together form a carbonyl group; or R.sup.64 and R.sup.65 taken together form a double bond; R.sup.71 is hydrogen and R.sup.72 is selected from --OH, --OC.sub.1-C.sub.10 alkyl, --OC.sub.2-C.sub.10 alkenyl, --Ocycloalkyl, --Oaryl, --Oheterocyclyl, --Oheteroaryl, --OC.sub.1-C.sub.10 alkylcycloalkyl, --OC.sub.1-C.sub.10 alkylaryl, --OC.sub.1-C.sub.10 alkylheterocyclyl, --OC.sub.1-C.sub.10 alkylheteroaryl and --OC(O)R; or R.sup.71 and R.sup.72 taken together form a carbonyl group; R.sup.73 to R.sup.76 are independently selected from hydrogen, --C.sub.1-C.sub.20 alkyl, --C.sub.2-C.sub.20 alkenyl, --C.sub.2-C.sub.20 alkynyl, --C.sub.3-C.sub.8 cycloalkyl, --C.sub.6-C.sub.14 aryl, --C.sub.5-C.sub.14 heteroaryl, --C.sub.3-C.sub.14 heterocyclyl, arylalkyl, heteroarylalkyl, heterocyclylalkyl, alkoxyalkyl, halo, --CN, --NO.sub.2, --C.sub.1-C.sub.10 haloalkyl, --C.sub.1-C.sub.10 dihaloalkyl, --C.sub.1-C.sub.10 trihaloalkyl, --COR, --CO.sub.2R, --OR, --SR, --N(R).sub.2, --NROR, --ON(R).sub.2, --SOR, --SO.sub.2R, --SO.sub.3R, --SON(R).sub.2, --SO.sub.2N(R).sub.2, --SO.sub.3N(R).sub.2, --P(R).sub.3, --P(O)(R).sub.3, --OSi(R).sub.3, --OB(R).sub.2, --C(W)R and --WC(W)R; or R.sup.74 and R.sup.75 taken together form a double bond or --O--; R.sup.77 and R.sup.78 are independently selected from hydrogen and --C.sub.1-C.sub.10 alkyl; W is selected from --O--, --S--, --NH-- and --N(C.sub.1-C.sub.6 alkyl)-; R is selected from hydrogen, --C.sub.1-C.sub.20 alkyl, --C.sub.2-C.sub.20 alkenyl, --C.sub.2-C.sub.20 alkenyl, --C.sub.3-C.sub.8 cycloalkyl, --C.sub.6-C.sub.14 aryl, --C.sub.5-C.sub.14 heteroaryl, --C.sub.3-C.sub.14 heterocyclyl, arylalkyl, heteroarylalkyl, heterocyclylalkyl, --C.sub.1-C.sub.10 haloalkyl, --C.sub.1-C.sub.10 dihaloalkyl and --C.sub.1-C.sub.10 trihaloalkyl; p and q are 0 or 1; and r is an integer from 1 to 8; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocyclyl and heteroaryl is optionally substituted; or a pharmaceutically, agriculturally or pesticidally acceptable salt thereof. 3. The method according to claim 1 wherein the compound of formula (II) is a compound of formula (III): ##STR00036## wherein: R.sup.50 is selected from --CH.sub.3, --C.sub.3-C.sub.8 cycloalkyl, aryl, heterocyclyl and heteroaryl; R.sup.51, R.sup.52, R.sup.57 and R.sup.58 are independently selected from hydrogen, --C.sub.1-C.sub.20 alkyl, --C.sub.2-C.sub.20 alkenyl, --C.sub.2-C.sub.20 alkynyl, --C.sub.3-C.sub.8 cycloalkyl, --C.sub.6-C.sub.14 aryl, --C.sub.5-C.sub.14 heteroaryl, --C.sub.3-C.sub.14 heterocyclyl, arylalkyl, heteroarylalkyl, heterocyclylalkyl, alkoxyalkyl, halo, --CN, --NO.sub.2, --C.sub.1-C.sub.10 haloalkyl, --C.sub.1-C.sub.10 dihaloalkyl, --C.sub.1-C.sub.10 trihaloalkyl, --COR, --CO.sub.2R, --OR, --SR, --N(R).sub.2, --NROR, --ON(R).sub.2, --SOR, --SO.sub.2R, --SO.sub.3R, --SON(R).sub.2, --SO.sub.2N(R).sub.2, --SO.sub.3N(R).sub.2, --P(R).sub.3, --P(O)(R).sub.3, --OSi(R).sub.3, --OB(R).sub.2, --C(O)R and --OC(O)R; R.sup.53 to R.sup.56 are independently selected from hydrogen, --C.sub.1-C.sub.20 alkyl, --C.sub.2-C.sub.20 alkenyl, --C.sub.2-C.sub.20 alkynyl, --C.sub.3-C.sub.8 cycloalkyl, --C.sub.6-C.sub.14 aryl, --C.sub.5-C.sub.14 heteroaryl, --C.sub.3-C.sub.14 heterocyclyl, arylalkyl, heteroarylalkyl, heterocyclylalkyl, alkoxyalkyl, halo, --CN, --NO.sub.2, --C.sub.1-C.sub.10 haloalkyl, --C.sub.1-C.sub.10 dihaloalkyl, --C.sub.1-C.sub.10 trihaloalkyl, --COR, --CO.sub.2R, --OR, --SR, --N(R).sub.2, --NROR, --ON(R).sub.2, --SOR, --SO.sub.2R, --SO.sub.3R, --SON(R).sub.2, --SO.sub.2N(R).sub.2, --SO.sub.3N(R).sub.2, --P(R).sub.3, --P(O)(R).sub.3, --OSi(R).sub.3, --OB(R).sub.2, --C(O)R and --OC(O)R; or R.sup.54 and R.sup.55 taken together form a double bond or --O--; R.sup.59 is hydrogen and R.sup.60 is selected from --OH, --OC.sub.1-C.sub.10 alkyl, --OC.sub.2-C.sub.10 alkenyl, --Ocycloalkyl, --Oaryl, --Oheterocyclyl, --Oheteroaryl, --OC.sub.1-C.sub.10 alkylcycloalkyl, --OC.sub.1-C.sub.10 alkylaryl, --OC.sub.1-C.sub.10 alkylheterocyclyl, --OC.sub.1-C.sub.10 alkylheteroaryl and --OC(O)R; or R.sup.59 and R.sup.60 taken together form a carbonyl group; R.sup.63 and R.sup.64 hydrogen; R.sup.65 is hydrogen and R.sup.66 is selected from --OH, --OC.sub.1-C.sub.10 alkyl, --OC.sub.2-C.sub.10 alkenyl, --Ocycloalkyl, --Oaryl, --Oheterocyclyl, --Oheteroaryl, --OC.sub.1-C.sub.10 alkylcycloalkyl, --OC.sub.1-C.sub.10 alkylaryl, --OC.sub.1-C.sub.10 alkylheterocyclyl, --OC.sub.1-C.sub.10 alkylheteroaryl and --OC(O)R; or R.sup.65 and R.sup.66 taken together form a carbonyl group; or R.sup.64 and R.sup.65 taken together form a double bond; R.sup.71 is hydrogen and R.sup.72 is selected from --OH, --OC.sub.1-C.sub.10 alkyl, --OC.sub.2-C.sub.10 alkenyl, --Ocycloalkyl, --Oaryl, --Oheterocyclyl, --Oheteroaryl, --OC.sub.1-C.sub.10 alkylcycloalkyl, --OC.sub.1-C.sub.10 alkylaryl, --OC.sub.1-C.sub.10 alkylheterocyclyl, --OC.sub.1-C.sub.10 alkylheteroaryl and --OC(O)R; or R.sup.71 and R.sup.72 taken together form a carbonyl group; R.sup.73 to R.sup.76 are independently selected from hydrogen, --C.sub.1-C.sub.20 alkyl, --C.sub.2-C.sub.20 alkenyl, --C.sub.2-C.sub.20 alkynyl, --C.sub.3-C.sub.8 cycloalkyl, --C.sub.6-C.sub.14 aryl, --C.sub.5-C.sub.14 heteroaryl, --C.sub.3-C.sub.14 heterocyclyl, arylalkyl, heteroarylalkyl, heterocyclylalkyl, alkoxyalkyl, halo, --CN, --NO.sub.2, --C.sub.1-C.sub.10 haloalkyl, --C.sub.1-C.sub.10 dihaloalkyl, --C.sub.1-C.sub.10 trihaloalkyl, --COR, --CO.sub.2R, --OR, --SR, --N(R).sub.2, --NROR, --ON(R).sub.2, --SOR, --SO.sub.2R, --SO.sub.3R, --SON(R).sub.2, --SO.sub.2N(R).sub.2, --SO.sub.3N(R).sub.2, --P(R).sub.3, --P(O)(R).sub.3, --OSi(R).sub.3, --OB(R).sub.2, --C(W)R and --WC(W)R; or R.sup.74 and R.sup.75 taken together form a double bond or --O--; R is selected from hydrogen, --C.sub.1-C.sub.20 alkyl, --C.sub.2-C.sub.20 alkenyl, --C.sub.2-C.sub.20 alkenyl, --C.sub.3-C.sub.8 cycloalkyl, --C.sub.6-C.sub.14 aryl, --C.sub.5-C.sub.14 heteroaryl, --C.sub.3-C.sub.14 heterocyclyl, arylalkyl, heteroarylalkyl, heterocyclylalkyl, --C.sub.1-C.sub.10 haloalkyl, --C.sub.1-C.sub.10 dihaloalkyl and --C.sub.1-C.sub.10 trihaloalkyl; p and q are 0 or 1; and r is an integer from 1 to 8; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocyclyl and heteroaryl is optionally substituted; or a pharmaceutically, agriculturally or pesticidally acceptable salt thereof. 4. The method according to claim 1, wherein in the compound of formula (II), X, Y and Z are oxygen. 5. The method according to claim 1 wherein in the compound of formula (II), R.sup.50 is --CH.sub.3, phenyl or heteroaryl. 6. The method according to claim 1 wherein in the compound of formula (II), R.sup.51, R.sup.52, R.sup.57 and R.sup.58 are hydrogen. 7. The method according to claim 1 wherein in the compound of formula (II), R.sup.53 to R.sup.56 are independently selected from hydrogen, --C.sub.1-C.sub.6 alkyl, --COC.sub.1-C.sub.6 alkyl, --CO.sub.2H, CO.sub.2 C.sub.1-C.sub.6 alkyl, --OH, --OC.sub.1-C.sub.6 alkyl and --OC(O)C.sub.1-C.sub.6 alkyl or R.sup.54 and R.sup.55 taken together form a double bond or --O--. 8. The method according to claim 1 wherein in the compound of formula (II), R.sup.59 is hydrogen and R.sup.60 is selected from --OH, --OC.sub.1-C.sub.10 alkyl, --OC.sub.2-C.sub.10 alkenyl, --Ocycloalkyl, --Oaryl, --Oheterocyclyl, --Oheteroaryl, --OC.sub.1-C.sub.10 alkylcycloalkyl, --OC.sub.1-C.sub.10 alkylaryl, --OC.sub.1-C.sub.10 alkylheterocyclyl, --OC.sub.1-C.sub.10 alkylheteroaryl and --OC(O)R; or R.sup.59 and R.sup.60 taken together form a carbonyl group. 9. The method according to claim 1 wherein in the compound of formula (II), R.sup.61, R.sup.62, R.sup.67, R.sup.68, R.sup.69 and R.sup.70 are hydrogen. 10. The method according to claim 1 wherein in the compound of formula (II), R.sup.63 and R.sup.64 are hydrogen. 11. The method according to claim 1 wherein in the compound of formula (II), R.sup.65 is hydrogen and R.sup.66 is selected from --OH, --OC.sub.1-C.sub.10 alkyl, --OC.sub.2-C.sub.10 alkenyl, --Ocycloalkyl, --Oaryl, --Oheterocyclyl, --Oheteroaryl, --OC.sub.1-C.sub.10 alkylcycloalkyl, --OC.sub.1-C.sub.10 alkylaryl, --OC.sub.1-C.sub.10 alkylheterocyclyl, --OC.sub.1-C.sub.10 alkylheteroaryl and --OC(O)R; or R.sup.59 and R.sup.60 taken together form a carbonyl group. 12. The method according to claim 1 wherein in the compound of formula (II), R.sup.64 and R.sup.65 form a double bond. 13. The method according to claim 1 wherein in the compound of formula (II), R.sup.71 is hydrogen and R.sup.72 is selected from --OH, --OC.sub.1-C.sub.10 alkyl, --OC.sub.2-C.sub.10 alkenyl, --Ocycloalkyl, --Oaryl, --Oheterocyclyl, --Oheteroaryl, --OC.sub.1-C.sub.10 alkylcycloalkyl, --OC.sub.1-C.sub.10 alkylaryl, --OC.sub.1-C.sub.10 alkylheterocyclyl, --OC.sub.1-C.sub.10 alkylheteroaryl and --OC(O)R; or R.sup.71 and R.sup.72 taken together form a carbonyl group. 14. The method according to claim 1 wherein in the compound of formula (II), R.sup.73, R.sup.74, R.sup.75 and R.sup.76 are hydrogen, or R.sup.73 and R.sup.76 are hydrogen and R.sup.74 and R.sup.75 taken together form a double bond or --O--. 15. The method according to claim 1 wherein in the compound of formula (II), R.sup.77 and R.sup.78 are independently hydrogen or methyl. 16. The method according to claim 1 wherein the treatment of said cancer further comprises administration of a further chemotherapeutic drug. 17. The method according to claim 16 wherein the further therapeutic drug is selected from cyclophosphamide, doxorubicine, etoposide phosphate, paclitaxel, topotecan, camptothecins, 5-fluorouracil, tamoxifen, staurosporine, avastin, erbitux, imatinib and vincristine.

Details for Patent 8,466,194

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Eli Lilly And Company	ERBITUX	cetuximab	Injection	125084	02/12/2004		2025-12-23
Eli Lilly And Company	ERBITUX	cetuximab	Injection	125084	03/28/2007		2025-12-23
Genentech, Inc.	AVASTIN	bevacizumab	Injection	125085	02/26/2004		2025-12-23